HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 1.79 Million USD | -62.72% |
| 2021 | 4.81 Million USD | 5.58% |
| 2020 | 4.55 Million USD | -55.72% |
| 2019 | 10.29 Million USD | -37.29% |
| 2018 | 16.41 Million USD | 67.69% |
| 2017 | 9.78 Million USD | 881.87% |
| 2016 | 996.84 Thousand USD | 41.18% |
| 2015 | 706.06 Thousand USD | 469.21% |
| 2014 | 124.04 Thousand USD | 3342.08% |
| 2013 | -3826.00 USD | -100.58% |
| 2012 | 664.62 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | - USD | 100.0% |
| 2023 Q1 | -117.09 Thousand USD | -128.73% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q4 | 407.55 Thousand USD | -29.73% |
| 2022 Q2 | 477.11 Thousand USD | 44.84% |
| 2022 Q1 | 329.4 Thousand USD | -78.36% |
| 2022 Q3 | 580.01 Thousand USD | 21.57% |
| 2022 FY | 1.79 Million USD | -62.72% |
| 2021 Q2 | 1.1 Million USD | 69.73% |
| 2021 Q3 | 1.53 Million USD | 39.3% |
| 2021 FY | 4.81 Million USD | 5.58% |
| 2021 Q4 | 1.52 Million USD | -0.95% |
| 2021 Q1 | 649.94 Thousand USD | -57.31% |
| 2020 Q4 | 1.52 Million USD | 82.07% |
| 2020 Q3 | 836.2 Thousand USD | -15.42% |
| 2020 Q2 | 988.65 Thousand USD | -18.29% |
| 2020 Q1 | 1.2 Million USD | -64.22% |
| 2020 FY | 4.55 Million USD | -55.72% |
| 2019 FY | 10.29 Million USD | -37.29% |
| 2019 Q4 | 3.38 Million USD | 37.14% |
| 2019 Q3 | 2.46 Million USD | -25.01% |
| 2019 Q2 | 3.28 Million USD | 184.11% |
| 2019 Q1 | 1.15 Million USD | -82.1% |
| 2018 FY | 16.41 Million USD | 67.69% |
| 2018 Q4 | 6.46 Million USD | 86.49% |
| 2018 Q1 | 3.02 Million USD | -53.89% |
| 2018 Q2 | 3.46 Million USD | 14.51% |
| 2018 Q3 | 3.46 Million USD | 0.19% |
| 2017 Q4 | 6.55 Million USD | 148.76% |
| 2017 FY | 9.78 Million USD | 881.87% |
| 2017 Q1 | 75.86 Thousand USD | -66.03% |
| 2017 Q2 | 523.85 Thousand USD | 590.49% |
| 2017 Q3 | 2.63 Million USD | 402.91% |
| 2016 Q3 | -211.1 Thousand USD | -121.93% |
| 2016 Q2 | 962.84 Thousand USD | 4324.41% |
| 2016 Q1 | 21.76 Thousand USD | -94.8% |
| 2016 FY | 996.84 Thousand USD | 41.18% |
| 2016 Q4 | 223.35 Thousand USD | 205.8% |
| 2015 FY | 706.06 Thousand USD | 469.21% |
| 2015 Q1 | 129.68 Thousand USD | 32.1% |
| 2015 Q4 | 418.83 Thousand USD | 107.4% |
| 2015 Q3 | 201.94 Thousand USD | 554.84% |
| 2015 Q2 | -44.39 Thousand USD | -134.23% |
| 2014 FY | 124.04 Thousand USD | 3342.08% |
| 2014 Q3 | 122.9 Thousand USD | 143.71% |
| 2014 Q2 | -281.14 Thousand USD | -252.7% |
| 2014 Q1 | 184.11 Thousand USD | 308.68% |
| 2014 Q4 | 98.17 Thousand USD | -20.12% |
| 2013 Q4 | -88.22 Thousand USD | 88.48% |
| 2013 FY | -3826.00 USD | -100.58% |
| 2013 Q2 | -1.13 Million USD | 0.0% |
| 2013 Q3 | -765.62 Thousand USD | 32.76% |
| 2012 FY | 664.62 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 1029.578% |
| Arrayit Corporation | 2.57 Million USD | 30.328% |
| Atlantic International Corp. | -154.23 Thousand USD | 1263.223% |
| Biocept, Inc. | -2.58 Million USD | 169.484% |
| Bioqual, Inc. | 7.42 Million USD | 75.851% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -550.031% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.973% |
| iMD Companies, Inc. | -23.63 Thousand USD | 7690.159% |
| IDenta Corp. | 662.97 Thousand USD | -170.611% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 92.214% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -2212.831% |
| InVitro International | 635.98 Thousand USD | -182.096% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 72.664% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -64.191% |
| NovelStem International Corp. | 12 Thousand USD | -14850.717% |
| Optigenex Inc. | -102.96 Thousand USD | 1842.406% |
| PharmChem, Inc. | 3.9 Million USD | 54.049% |
| Proteome Sciences plc | 2.09 Million USD | 14.43% |
| Response Genetics, Inc | 3.94 Million USD | 54.488% |
| Rennova Health, Inc. | 6.26 Million USD | 71.378% |
| RushNet, Inc. | 1.1 Million USD | -62.417% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -109.449% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 544.359% |
| Todos Medical Ltd. | 4.31 Million USD | 58.374% |